1. Metabolic inhibitors accentuate the anti-tumoral effect of HDAC5 inhibition
    E Hendrick et al, 2017, Oncogene CrossRef
  2. RmiR-133a enhances the sensitivity of Hep-2 cells and vincristine-resistant Hep-2v cells to cisplatin by downregulating ATP7B expression
    XURUI WANG et al, 2016 CrossRef
  3. Iron metabolism and drug resistance in cancer.
    Hasan Huseyin Kazan et al, 2017, Biometals CrossRef
  4. Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and disease
    Keith Richard Mitchelson, 2015, WJBC CrossRef
  5. Lipocalin-2 and iron trafficking in the tumor microenvironment
    Michaela Jung et al, 2017, Pharmacological Research CrossRef
  6. Piperazinyl fragment improves anticancer activity of Triapine
    Marta Rejmund et al, 2018, PLoS ONE CrossRef
  7. Epigenetic Regulation by Sulforaphane: Opportunities for Breast and Prostate Cancer Chemoprevention
    Lauren L. Atwell et al, 2015, Curr Pharmacol Rep CrossRef
  8. Alterations in Cellular Iron Metabolism Provide More Therapeutic Opportunities for Cancer
    Liangfu Zhou et al, 2018, IJMS CrossRef
  9. 4′-Phenyl-2,2′:6′,2′′-terpyridine Derivatives Containing 1-Substituted-2,3-Triazole Ring: Synthesis, Characterization and Anticancer Activity
    Dawid Zych et al, 2018, ChemistrySelect CrossRef
  10. Co-polysomy of 1p/19q in glial tumors: Retrospective analysis of 221 cases from single center
    Aysegul Kuskucu et al, 2019, Gene CrossRef
  11. The iron chelator desferrioxamine synergizes with chemotherapy for cancer treatment
    Lingjuan Wang et al, 2019, Journal of Trace Elements in Medicine and Biology CrossRef
  12. Iron-free and iron-saturated bovine lactoferrin inhibit survivin expression and differentially modulate apoptosis in breast cancer
    Jessica A. Gibbons et al, 2015, BMC Cancer CrossRef
  13. STATE AND PROSPECTS OF IMPLEMENTATION NANOTECHNOLOGY IN BIOLOGY AND MEDICINE Information from scientific report at the meeting of Presidium of NAS of Ukraine, April 29, 2015
    V.F. Chekhun, 2015, Visn. Nac. akad. nauk Ukr CrossRef
  14. Ferritin Light Chain (FTL) competes with long noncoding RNA Linc00467 for miR-133b binding site to regulate chemoresistance and metastasis of colorectal cancer
    Zengyao Li et al, 2019 CrossRef
  15. Immunoreactivities for hepcidin, ferroportin, and hephaestin in astrocytes and choroid plexus epithelium of human brains
    Ken Yanase et al, 2019, Neuropathology CrossRef
  16. Iron protects childhood acute lymphoblastic leukemia cells from methotrexate cytotoxicity
    Marjan Abedi et al, 2020, Cancer Med CrossRef
  17. Molecular avenues in targeted doxorubicin cancer therapy
    Sayantani Roychoudhury et al, 2020, Future Oncology CrossRef
  18. NGAL promotes recruitment of tumor infiltrating leukocytes
    Francesco Pacifico et al, 2018, Oncotarget CrossRef
  19. The role of oxidative stress in activity of anticancer thiosemicarbazones
    Katarzyna Malarz et al, 2018, Oncotarget CrossRef
  20. Myoferlin is a novel exosomal protein and functional regulator of cancer-derived exosomes
    Arnaud Blomme et al, 2016, Oncotarget CrossRef
  21. Iron: Key player in cancer and cell cycle?
    Azmi Khan et al, 2020, Journal of Trace Elements in Medicine and Biology CrossRef
  22. Immune system‑associated genes increase malignant progression and can be used to predict clinical outcome in patients with hepatocellular carcinoma
    Rongfu Huang et al, 2020, Int J Oncol CrossRef
  23. Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma.
    Junhui Liu et al, 2020, J Exp Clin Cancer Res CrossRef
  24. Crosstalk between noncoding RNAs and ferroptosis: new dawn for overcoming cancer progression
    Xuefei Zhang et al, 2020, Cell Death Dis CrossRef
  25. Ferroptosis in Cancer Treatment: Another Way to Rome.
    Yinan Wu et al, 2020, Front Oncol CrossRef

  26. Inflammation Mediated Hepcidin-Ferroportin Pathway and Its Therapeutic Window in Breast Cancer


    Tewodros Shibabaw et al, 2020, BCTT CrossRef
  27. Theranostic Prospects of Graphene Quantum Dots in Breast Cancer
    Rahul S. Tade et al, 2020, ACS Biomater. Sci. Eng. CrossRef
  28. PREDICTIVE SIGNIFICANCE OF HIGH SERUM FERRITIN LEVELS IN THE DEBUT OF MALIGNANT LYMPHOMA
    Babaeva T.N. et al, 2020, Mediko-farmacevtičeskij žurnal "Pulʹs" CrossRef
  29. Explaining decisions of graph convolutional neural networks: patient-specific molecular subnetworks responsible for metastasis prediction in breast cancer
    Hryhorii Chereda et al, 2021, Genome Med CrossRef
  30. MYCN mediates TFRC-dependent ferroptosis and reveals vulnerabilities in neuroblastoma
    Yuxiong Lu et al, 2021, Cell Death Dis CrossRef
  31. RNA sequencing identified novel target genes for Adansonia digitata in breast and colon cancer cells
    Omar S. El-Masry et al, 2021, Science Progress CrossRef
  32. Emerging role of ferroptosis in breast cancer: New dawn for overcoming tumor progression
    Shiyao Sui et al, 2021, Pharmacology & Therapeutics CrossRef
  33. A Ferroptosis-Related Gene Signature for Predicting the Prognosis and Drug Sensitivity of Head and Neck Squamous Cell Carcinoma
    Wei Lu et al, 2021, Front. Genet. CrossRef
  34. Iron Promotes Cardiac Doxorubicin Retention and Toxicity Through Downregulation of the Mitochondrial Exporter ABCB8
    Archita Venugopal Menon et al, 2022, Front. Pharmacol. CrossRef
  35. Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review
    Pía Loren et al, 2022, Front. Pharmacol. CrossRef
  36. The Role of miRNAs in the Resistance of Anthracyclines in Breast Cancer: A Systematic Review
    Zihan Si et al, 2022, Front. Oncol. CrossRef
  37. Puzzling Out Iron Complications in Cancer Drug Resistance
    Marjan Abedi et al, 2022, Critical Reviews in Oncology/Hematology CrossRef
  38. Lipid metabolism in ferroptosis and ferroptosis-based cancer therapy
    Yonghao Sun et al, 2022, Front. Oncol. CrossRef
  39. Iron metabolism, ferroptosis, and lncRNA in cancer: knowns and unknowns
    Lei Qu et al, 2022, J. Zhejiang Univ. Sci. B CrossRef
  40. Therapy-resistant nature of cancer stem cells in view of iron metabolism
    Wenqian Wang et al, 2022, Inflamm Regener CrossRef
  41. New Insights into Ferroptosis Initiating Therapies (FIT) by Targeting the Rewired Lipid Metabolism in Ovarian Cancer Peritoneal Metastases
    Shijie Zhan et al, 2022, IJMS CrossRef
  42. Osimertinib-tolerant lung cancer cells are susceptible to ferroptosis
    Hiroto Konishi et al, 2022, Biochemical and Biophysical Research Communications CrossRef
  43. Emerging role of miRNAs in the regulation of ferroptosis
    Reza Mahmoudi-Lamouki et al, 2023, Front. Mol. Biosci. CrossRef
  44. A novel view of ferritin in cancer
    Bhavyata (Pandya) Shesh et al, 2023, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  45. Orally Administered Curcumin Inhibits Breast Cancer In vivo and Reduces Cell Proliferation In vitro in an Iron Dependent Manner
    Marce Inzunza-Soto et al, 2023, CNF CrossRef
  46. Noncoding RNAs in cancer ferroptosis: From biology to clinical opportunity
    Chan Shan et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  47. Iron Metabolism in Cancer and Senescence: A Cellular Perspective
    Elvira Crescenzi et al, 2023, Biology CrossRef
  48. Overexpression of ferritin light chain as a poor prognostic factor for breast cancer
    Chunxiao Tang et al, 2023, Mol Biol Rep CrossRef
  49. Peculiarities of interaction of malignant cells and tumors with chemotherapeutic nanocomposite remedies
    S.P. Turanska et al, 2023, Poverhn. CrossRef
  50. ABCB1‐mediated docetaxel resistance reversed by erastin in prostate cancer
    Fangfang Chen et al, 2024, The FEBS Journal CrossRef
  51. Iron promotes ovarian cancer malignancy and advances platinum resistance by enhancing DNA repair via FTH1/FTL/POLQ/RAD51 axis
    Qingyu Zhang et al, 2024, Cell Death Dis CrossRef